Navigation Links
Climate-caused biodiversity booms and busts in ancient plants and mammals
Date:8/6/2009

earchers found.

"This is also the part of the Eocene when we see the most new appearances of mammals due to evolutionary innovation, rather than immigration," said Stucky, who is curator of paleoecology and evolution at the Denver Museum of Nature & Science. Some 30 new rodents, carnivores, primates and artiodactyls (the group that includes sheep, goats, camels, pigs, cows, deer, giraffes and antelopes, among others) appeared on the scene.

But then, as temperatures declined again, the number of mammal genera dropped to a low of 84, with the complete loss of many mammalian groups that previously were well represented. Lower temperatures and a dryer climate continued to influence mammal and plant evolution as savanna habitats began to emerge.

Until this research, the consensus among paleontologists who study North American vertebrates was that climate played only a background role in supporting the evolution of mammals during the Paleocene and Eocene (65 million to 35 million years ago) and that only at the end of the Eocene, when Antarctic glaciations began, did Earth's climate deteriorate enough to cause observable changes in land mammal diversity.

"Our paper documents the fact that global change affected plants and animals on a wide scale," said Gunnell, an associate research scientist and vertebrate collection coordinator at the U-M Museum of Paleontology. "Some plants and animals flourished while others suffered."

When considering today's global warming, Woodburne said, "The question is, on which side of this picture will mankind be found?"


'/>"/>

Contact: Nancy Ross-Flanigan
rossflan@umich.edu
734-647-1853
University of Michigan
Source:Eurekalert

Page: 1 2

Related biology news :

1. New theory gives more precise estimates of large-scale biodiversity
2. Academy Library accepted to prestigious Biodiversity Heritage Library
3. Scorpion biodiversity
4. K-State biologist collaborating with researchers in Africa on grassland sustainability, biodiversity
5. Threats to biodiversity rise in the worlds Mediterranean-climate regions
6. Biodiversity itself begets a species cascade, researchers say
7. The global impact of climate change on biodiversity
8. Alpine rivers hold important clues for preserving biodiversity and coping with climate change
9. Networks of small habitat patches can preserve urban biodiversity
10. Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told
11. Marine invasive species advance 50km per decade, World Conference on Marine Biodiversity told

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...dust: Toxins in coal-tar-based sealcoats in parkin...st, according to a USGS study. PAHs or polycycli... in oil, coal and tar deposits, and can have toxic... found in house dust; however, the specific source...ers found that dust from indoor areas near parking...
(Date:11/20/2009)...uctive pulmonary disease (COPD), a respiratory dis...sema, is the fourth leading cause of death worldwi...esearchers have yet to find any real treatment or ...at The University of Western Ontario in London, Ca...new insight into the disease. , Parraga is a...
(Date:11/19/2009)...-cutter ants, which cultivate fungus for food, hav... to add to the list: the ant farmers, like their h...ria to make their gardens grow. The finding, repor...documents a previously unknown symbiosis between a...f-cutter ants have come to dominate the American t...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 2ISSA Announces New Specialist in Fitness Nutrition Certification 52175 1ISSA Announces New Specialist in Fitness Nutrition Certification 52175 2Pharmaxis Investor Conference Call 13112 1New report 3A Individual health insurance market failing consumers 52173 1New report 3A Individual health insurance market failing consumers 52173 2New report 3A Individual health insurance market failing consumers 52173 3New report 3A Individual health insurance market failing consumers 52173 4
...ome,Research that they have successfully cloned an...nce: a 554-kilobase-pair genomic,segment near the ...e,contains eight putatively active genes that coul...es and gonadal tumor development. , This,pericentr...he,"finished" sequence of the human genome reporte...
...that was originally believed to be involved in tub...sing enzyme" from the biosynthetic pathway for an ... research appears as the "Paper of the Week" in th...stry, an American Society for Biochemistry and Mol...sis, the causative agent of tuberculosis, is respo...
...r,has been announced by Agilent Technologies. The ...bles the rapid advance of microarray-based,compara...eport,published in the December 24, 2004 issue of ... (PNAS) in collaboration with the National,Human G...specialised,microarray platform that uses total ge...
Other Biology News:Found: Missing sequence of the human Y chromosome 2Found: Missing sequence of the human Y chromosome 3Scientists find missing enzyme for tuberculosis iron scavenging pathway 2Breakthrough Microarray-based Technology for the Study of Cancer 2
(Date:11/20/2009)...PRNewswire/ -- Karolinska Development AB today,ann... entered into a,co-investment agreement with the c...Karolinska Development and used to invest in the c...nd medical technology companies. EIF,has agreed to...e agreement,represents EIF,s largest single invest...
(Date:11/19/2009)...arge their cell phones and other personal electron...made by UC San Diego engineers could lead to carbo...t this. , In recent research, published in App...sor in the UCSD Department of Mechanical and Aeros... Hoefer, have found that artificially introduced d...
(Date:11/19/2009)...19 Spherix Incorporated ...r diabetes therapy, and a provider of technical an...nt, biotechnology and pharmaceutical companies, an....3 million registered direct placement to institut...stock and warrants to purchase up to 1,104,348 add...
(Date:11/19/2009)...r 19 MONITORING FORCE GmbH,announc...banserin in the,indication treatment-relevant levo... orphan drug status designation with the European ...ia is a complication of the mainstay,treatment in ...of those,affected, since it may be disabling for t...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...8 Bio-Pharma executives are,increasingly finding ...d by,Best Practices, LLC and in particular in use ... Best Practice Database (, http://www.BestPractice...ase,may be accessed and downloaded individually, m... find outstanding value in membership to the datab...
...harmaceuticals,(Nasdaq: SGXP ) today announced it...nded June 30, 2008. For the three months ended Jun...llion and a net loss of $7.2 million. For,the six ...llion and the net,loss was $3.5 million. The reven...of revenue earned in the first quarter attributabl...
...if., Aug. 7 Anesiva,Inc. (Nasdaq: ANSV ) today r...the second quarter and six months ended June 30, 2...nt advance for Anesiva as we,introduced Zingo(TM) ...el,L. Kranda, president and chief executive office...ase 3 trials of Adlea(TM) for the management of ac...
Other Biology Technology:Best Practice Database Supports Bio-Pharma Product Launch 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 4SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 5SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 6SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 7SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 8SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 9Anesiva Announces Second Quarter 2008 Financial Results and Update 2Anesiva Announces Second Quarter 2008 Financial Results and Update 3Anesiva Announces Second Quarter 2008 Financial Results and Update 4Anesiva Announces Second Quarter 2008 Financial Results and Update 5Anesiva Announces Second Quarter 2008 Financial Results and Update 6Anesiva Announces Second Quarter 2008 Financial Results and Update 7Anesiva Announces Second Quarter 2008 Financial Results and Update 8
Rat Adrenal from Pel-Freez Biologicals
GIBCO BGJb Medium (Fitton-Jackson Modification) (1X) liquid from Invitrogen
Mouse Anti-MMP-20 Monoclonal Antibody, Unconjugated, Clone MMP2/2C1 from ABR-Affinity BioReagents
RSK2 siRNA siAb™ Assay Kit from Upstate
Biology Products: